Inventor · disambiguated record
Rusty L. Montgomery
Also filed as: MONTGOMERY RUSTY · MONTGOMERY RUSTY L · MONTGOMERY RUSTY LEE
11 granted patents·5 pending applications·34 citations·filing 2009–2025
86Inventor score
Files withMIRAGEN THERAPEUTICS INC10BIOAGE LABS INC2DALBY CHRISTINA1MIRAGEN THERAPEUTICS1OLSON ERIC N1
Top patents by PatentIndex Score
16 records- 0189US9376681B2miR-29 mimics and uses thereofMIRAGEN THERAPEUTICS INC·Filed 2015·Granted Jun 28, 2016·9 cites·12 claims
- 0287US9388408B2Oligonucleotide-based inhibitors comprising locked nucleic acid motifMIRAGEN THERAPEUTICS INC·Filed 2013·Granted Jul 12, 2016·9 cites·14 claims
- 0383US8642751B2MicroRNA inhibitors comprising locked nucleotidesDALBY CHRISTINA·Filed 2011·Granted Feb 4, 2014·10 cites·13 claims
- 0479US9803202B2Oligonucleotide-based inhibitors comprising locked nucleic acid motifMIRAGEN THERAPEUTICS INC·Filed 2016·Granted Oct 31, 2017·2 cites·25 claims
- 0572US9994847B2miR-29 mimics and uses thereofMIRAGEN THERAPEUTICS INC·Filed 2016·Granted Jun 12, 2018·1 cites·32 claims
- 0670US9752144B2Inhibitors of MYH7B and uses thereofMIRAGEN THERAPEUTICS INC·Filed 2015·Granted Sep 5, 2017·1 cites·29 claims
- 0768US9428749B2Control of whole body energy homeostasis by microRNA regulationUNIV TEXAS·Filed 2012·Granted Aug 30, 2016·2 cites·19 claims
- 0860US10337005B2Oligonucleotide-based inhibitors comprising locked nucleic acid motifMIRAGEN THERAPEUTICS INC·Filed 2017·Granted Jul 2, 2019·0 cites·24 claims
- 0955US2024122926A1Apelin receptor modulators for treating muscle conditionsBIOAGE LABS INC·Filed 2023·Application pending·0 cites
- 1055US2010212036A1Selective inhibition of histone deacetylases 1 and 2 as a treatment for cardiac hypertrophyOLSON ERIC N·Filed 2009·Application pending·0 cites
- 1154US10144930B2Inhibitors of MYH7B and uses thereofMIRAGEN THERAPEUTICS INC·Filed 2017·Granted Dec 4, 2018·0 cites·24 claims
- 1254US2019127734A1Mir-29 mimics and uses thereofMIRAGEN THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 1348US2020318113A1Polynucleotide conjugates and uses thereofMIRAGEN THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1447US9752143B2Locked nucleic acid inhibitor of miR-145 and uses thereofMIRAGEN THERAPEUTICS INC·Filed 2014·Granted Sep 5, 2017·0 cites·19 claims
- 1546US2014187603A1Microrna inhibitors comprising locked nucleotidesMIRAGEN THERAPEUTICS·Filed 2013·Application pending·0 cites
- 1645US12509459B2Inhibitors of NLRP3 inflammasomeBIOAGE LABS INC·Filed 2025·Granted Dec 30, 2025·0 cites·29 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →